Physician profile
Luka Petrovic
NPI 1083066435
$10,536.01
in general payments reported to CMS, 2019-2025
11 companies · $11K in 2025
The $11K reported for 2025 was more than what 81% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $21.39 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $5,000 · Food and Beverage: $2,824 · Travel and Lodging: $2,671 · Entertainment: $41.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $5,000.00 |
| Food and Beverage | $2,823.95 |
| Travel and Lodging | $2,670.50 |
| Entertainment | $41.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,641.71 | 2025 | Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor, General - Therapies |
| Abbott Laboratories | $2,537.50 | 2025 | Ensite, Aveir, Gallant |
| Biosense Webster, INC. | $1,214.92 | 2025 | Carto 3, Nuvision Ice Catheter |
| Biotronik INC. | $641.01 | 2025 | Acticor 7 Vr-T Dx |
| Medtronic, INC. | $169.72 | 2025 | Micra, Aurora Ev-Icd Mri Surescan, Linq II |
| Novartis Pharmaceuticals Corporation | $157.62 | 2025 | |
| Scpharmaceuticals INC. | $49.13 | 2025 | |
| Stereotaxis INC | $41.56 | 2025 | Genesis |
| Kestra Medical Technology Services, INC. | $40.23 | 2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $21.39 | 2024 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $21.22 | 2025 | Lokelma |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luka Petrovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.